老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aimmune Therapeutics, Inc.

34.49
0.0000
成交量：- -
成交額：- -
市值：22.68億
市盈率：-7.68
高：34.49
開：34.49
低：34.49
收：34.49
52周最高：37.00
52周最低：10.09
股本：6,576.68萬
流通股本：4,320.00萬
量比：- -
換手率：- -
股息：- -
股息率：- -
每股收益(TTM):-4.4923
每股收益(LYR):-3.9723
淨資產收益率：-149.17%
總資產收益率：-53.24%
市淨率：12.61
市盈率(LYR):-8.68

資料載入中...

總覽公司新聞資訊公告
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/10/19

重要事件披露

8-K - Current report
2020/10/13

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/10/13

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/10/13

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/10/13

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/10/13

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/10/13

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/10/13

私有化交易

SC 13E3/A [Amend] - Going private transaction by certain issuers
2020/10/13

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/10/13

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2020/10/08

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/05

SEC問詢函

CORRESP [Cover] - Correspondence
2020/09/29

私有化交易

SC 13E3/A [Amend] - Going private transaction by certain issuers
2020/09/21

私有化交易

SC 13E3/A [Amend] - Going private transaction by certain issuers
2020/09/14

私有化交易

SC 13E3 - Going private transaction by certain issuers
2020/08/31

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/08/31

重要事件披露

8-K - Current report
2020/07/31

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/07/30

重要事件披露

8-K - Current report
更多